Keertan Dheda Selected Research

Keertan Dheda Research Topics

Disease

87	Tuberculosis (Tuberculoses) 05/2024 - 09/2004
26	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2023 - 05/2010
17	Infections 05/2024 - 05/2006
17	Extensively Drug-Resistant Tuberculosis 03/2024 - 09/2010
12	COVID-19 01/2024 - 11/2020
12	Pulmonary Tuberculosis 12/2023 - 07/2004
11	Latent Tuberculosis 01/2020 - 07/2004
9	Coinfection 08/2019 - 10/2005
7	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2019 - 11/2009
6	HIV Infections (HIV Infection) 01/2023 - 01/2008
5	Cough 05/2024 - 10/2005
4	Drug-Related Side Effects and Adverse Reactions 01/2022 - 02/2010
3	Tuberculous Pericarditis 03/2024 - 06/2014
3	Pneumonia (Pneumonitis) 10/2023 - 11/2020
3	Asthma (Bronchial Asthma) 12/2021 - 09/2015
3	Emphysema 09/2015 - 01/2015
2	Pericarditis 03/2024 - 11/2011
2	Extrapulmonary Tuberculosis 01/2021 - 01/2018
2	Fever (Fevers) 01/2021 - 01/2021
2	Drug Hypersensitivity Syndrome 09/2016 - 09/2015
2	Necrosis 04/2014 - 09/2004
2	Acquired Immunodeficiency Syndrome (AIDS) 10/2005 - 11/2004
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2005 - 09/2004
1	Reinfection 12/2023
1	Breakthrough Infections 01/2023
1	Critical Illness (Critically Ill) 01/2023
1	Inflammation (Inflammations) 10/2022
1	Anemia 01/2022
1	Hearing Loss (Hearing Impairment) 01/2022
1	Dyspnea (Shortness of Breath) 01/2021

Drug/Important Bio-Agent (IBA)

20	lipoarabinomannan (LAM)IBA 01/2023 - 01/2009
16	Rifampin (Rifampicin)FDA LinkGeneric 12/2023 - 09/2010
14	VaccinesIBA 05/2024 - 09/2004
14	bedaquiline (R207910)IBA 03/2024 - 03/2014
14	Interferon-gamma (Interferon, gamma)IBA 02/2019 - 07/2004
12	AntigensIBA 01/2019 - 05/2005
11	Linezolid (Zyvox)FDA Link 03/2024 - 03/2014
10	Tuberculin (PPD)IBA 01/2020 - 05/2006
9	Nucleic AcidsIBA 01/2022 - 01/2009
9	CytokinesIBA 01/2019 - 05/2004
8	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2014
8	InterferonsIBA 03/2024 - 10/2005
7	Isoniazid (Ftivazide)FDA LinkGeneric 12/2023 - 09/2010
7	Proteins (Proteins, Gene)FDA Link 10/2023 - 05/2006
6	FluoroquinolonesIBA 03/2024 - 07/2013
6	ChAdOx1 nCoV-19IBA 01/2023 - 01/2021
6	GoldIBA 07/2020 - 02/2010
6	Messenger RNA (mRNA)IBA 08/2007 - 07/2004
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2016
5	Interleukin-4 (Interleukin 4)IBA 01/2019 - 09/2004
4	AerosolsIBA 05/2024 - 10/2005
4	Antitubercular AgentsIBA 01/2023 - 04/2012
3	tributyl phosphate (TBP)IBA 03/2024 - 06/2014
3	COVID-19 VaccinesIBA 01/2023 - 01/2022
3	InterleukinsIBA 01/2019 - 08/2005
3	Interleukin-10 (Interleukin 10)IBA 01/2018 - 08/2006
3	Capreomycin (Capastat)FDA Link 01/2017 - 01/2013
2	6-chloropenicillanic acid S-sulfoxideIBA 05/2024 - 01/2017
2	Moxifloxacin (Avelox)FDA Link 12/2023 - 05/2010
2	Meropenem (Merrem)FDA LinkGeneric 12/2023 - 01/2019
2	Oxygen (Dioxygen)IBA 11/2023 - 11/2020
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2023
2	Interleukin-13IBA 10/2022 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 09/2015
2	Ethionamide (Trecator-SC)FDA Link 01/2021 - 09/2015
2	Clofazimine (Lamprene)FDA Link 01/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2019 - 07/2004
2	Pyrazinamide FDA LinkGeneric 01/2018 - 07/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 01/2012
2	Adenosine DeaminaseIBA 06/2014 - 01/2009
2	LatexIBA 11/2011 - 08/2010
2	Coloring Agents (Dyes)IBA 11/2011 - 08/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2005 - 09/2004
1	AIDS VaccinesIBA 05/2024
1	pretomanidIBA 12/2023
1	MacrolidesIBA 10/2023
1	ProteomeIBA 10/2023
1	anti-IgGIBA 01/2023
1	AntibodiesIBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	Fc Receptors (Fc Receptor)IBA 01/2023
1	Untranslated RNA (Noncoding RNA)IBA 10/2022
1	Kanamycin FDA Link 01/2022
1	NanovaccinesIBA 01/2022
1	NVX-CoV2373 adjuvated lipid nanoparticleIBA 01/2021
1	Alanine (L-Alanine)FDA Link 01/2021

Therapy/Procedure

17	Therapeutics 01/2023 - 01/2008
5	Art Therapy 01/2018 - 01/2008
4	Duration of Therapy 01/2023 - 01/2018
3	Injections 01/2022 - 01/2018
3	Bronchial Thermoplasty 12/2021 - 09/2015
3	Pneumonectomy (Lung Volume Reduction) 09/2015 - 01/2015
3	Highly Active Antiretroviral Therapy (HAART) 04/2012 - 11/2004
2	Self-Testing 01/2024 - 01/2021
2	Aftercare (After-Treatment) 08/2019 - 05/2006
2	Drug Therapy (Chemotherapy) 01/2019 - 03/2017
1	Enteral Nutrition (Feeding, Tube) 01/2023
1	Drug Substitution 01/2022